Intervention

Shigeo Godo , Jun Takahashi , Takashi Shiroto , et al

Read time: 13 Mins
CRT 23: Findings From a Sub-Analysis of the EASTBOURNE Trial

Bernardo Cortese,

Watch time: 5m 21s
CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
CRT 23: The OPTIMAL Randomized Controlled Trial

José M de la Torre Hernández,

Watch time: 6m 1s

Prakriti Gaba, Joost Daemen, Bernardo Cortese, et al

Watch time: 22m 47s (4 videos)
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti,

Watch time: 12m 7s

Mirvat Alasnag, Khaled Al-Shaibi, Erin D Michos, et al

ACC 23: The Evolut Low Risk Trial

John Forrest,

Watch time: 3m 46s
ACC 23: The UK Mini Mitral Study

Enoch Akowuah,

Watch time: 5m 41s
ACC 23: RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI

Joo-Yong Hahn,

Watch time: 5m 38s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
AI powered CT based Non Invasive CAD testing

Derek Connolly, , , et al

Jonathan Hill, James Spratt, Charalambos Antoniades, et al

Watch time: 11h 6m (20 videos)

Nicolas M Van Mieghem, Peter Lüdike, Philipp Lurz, et al

Remo Albiero ,

Dae-Hyun Lee , José M de la Torre Hernández ,

Georgia Tsoumakidou , Elias Brountzos ,

Nicolas M Van Mieghem, Philipp Lurz, Philip Raake, et al

Fernando Alfonso ,

Yukiko Isekame , Sabiha Gati , Jose Antonio Aragon-Martin , et al

Alejandro de la Sierra ,

Stefan Tunev, Andrew SP Sharp,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Media

Prakriti Gaba, Joost Daemen, Bernardo Cortese, et al

Watch time: 22m 47s (4 videos)
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti,

Watch time: 12m 7s

Mirvat Alasnag, Khaled Al-Shaibi, Erin D Michos, et al

ACC 23: The Evolut Low Risk Trial

John Forrest,

Watch time: 3m 46s
ACC 23: RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI

Joo-Yong Hahn,

Watch time: 5m 38s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC 23 Late-breaker Discussion: The REVIVED-BCIS2 Viability Study

Harriette Van Spall, Divaka Perera, Peter O’Kane, et al

Watch time: 16m 24m
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Atul Pathak, Joost Daemen, Joachim Weil, et al

Intracoronary Imaging in Acute Coronary Syndromes

Ziad A Ali,

Watch time: 4m 28s
UK Perspective on Cerebral Embolic Protection

Sam Dawkins,

Watch time: 2m 42s
PCI for Ischemic Left Ventricular Dysfunction in 2023

Angela Hoye, Rodney H Stables, Anthony Mathur, et al

Watch time: 18m 25s
Use of Cerebral Embolic Protection in 2023

Vijay Kunadian, Richard J Jabbour, Rajesh Kharbanda, et al

Watch time: 24m 10s
Ep 82: Hospital Peer Review Process: What You Need to Know as a Physician

Ankur Kalra, Amir Kaki, , et al

Listen time: 55m 32s

Hasan Jilaihawi, João L Cavalcante, Nicolas M Van Mieghem, et al

Watch time: 2h 57m (14 videos)
Ep 81: @Medlife Crisis and Authenticity with YouTuber & Interventionalist, Dr Rohin Francis

Ankur Kalra, Rohin Francis,

Listen time: 44:41
AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 30m
View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 35m 25s

Joseph A Hill, Mirvat Alasnag,

View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s
USC Discussion 2022: The Multidisciplinary Heart Team in AS

Kendra J Grubb, Suzanne J Baron,

Watch time: 16m 13s
EP 8: The Role of CT Coronary Angiography in CTO Intervention

Vinoda Sharma, Abdul Mozid,

Watch time: 23m 15s
View from the Thoraxcenter: TCT 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 37m 13s
PREDICT-LAA

Ole De Backer,

Watch time: 04:01
Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention

Natalia Berry, Renée Bullock-Palmer,

Watch time: 25m 41s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 56m (11 videos)
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Watch time: 3:52:31

Media

CRT 23: Findings From a Sub-Analysis of the EASTBOURNE Trial

Bernardo Cortese,

Watch time: 5m 21s
CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
CRT 23: The OPTIMAL Randomized Controlled Trial

José M de la Torre Hernández,

Watch time: 6m 1s

Prakriti Gaba, Joost Daemen, Bernardo Cortese, et al

Watch time: 22m 47s (4 videos)
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti,

Watch time: 12m 7s

Mirvat Alasnag, Khaled Al-Shaibi, Erin D Michos, et al

ACC 23: The Evolut Low Risk Trial

John Forrest,

Watch time: 3m 46s
ACC 23: The UK Mini Mitral Study

Enoch Akowuah,

Watch time: 5m 41s
ACC 23: RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI

Joo-Yong Hahn,

Watch time: 5m 38s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba,

Watch time: 4m 19s
ACC 23 Late-breaker Discussion: The REVIVED-BCIS2 Viability Study

Harriette Van Spall, Divaka Perera, Peter O’Kane, et al

Watch time: 16m 24m
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Atul Pathak, Joost Daemen, Joachim Weil, et al

Intracoronary Imaging in Acute Coronary Syndromes

Ziad A Ali,

Watch time: 4m 28s
UK Perspective on Cerebral Embolic Protection

Sam Dawkins,

Watch time: 2m 42s
PCI for Ischemic Left Ventricular Dysfunction in 2023

Angela Hoye, Rodney H Stables, Anthony Mathur, et al

Watch time: 18m 25s
Use of Cerebral Embolic Protection in 2023

Vijay Kunadian, Richard J Jabbour, Rajesh Kharbanda, et al

Watch time: 24m 10s
Ep 82: Hospital Peer Review Process: What You Need to Know as a Physician

Ankur Kalra, Amir Kaki, , et al

Listen time: 55m 32s

Hasan Jilaihawi, João L Cavalcante, Nicolas M Van Mieghem, et al

Watch time: 2h 57m (14 videos)
PCR London Valves 22: Vienna Aortic Valve TAVI System in Pts with AS

Kasparas Briedis,

Watch time: 11m 33s
Ep 81: @Medlife Crisis and Authenticity with YouTuber & Interventionalist, Dr Rohin Francis

Ankur Kalra, Rohin Francis,

Listen time: 44:41
AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s
AHA 22: SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension

David Kandzari,

Watch time: 10m 6s
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 4s

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 30m
View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 35m 25s

Joseph A Hill, Mirvat Alasnag,

Articles

TAVI in Challenging Scenarios

Sandra Santos-Martínez

,

Ignacio J Amat-Santos

,

Published:

26 August 2021

Citation:

European Cardiology Review 2021;16:e29.

DOI:

https://doi.org/10.15420/ecr.2021.12
  • Views: Views 2137
  • Downloads: Downloads 123
  • Citations: 2

APSC Consensus Recommendations for MitraClip in MR

Khung Keong Yeo

,

Jack Wei Chieh Tan

,

David WM Muller

,

Darren L Walters

,

JoAnn Lindenfeld

,

Michael Kang-Yin Lee

,

Angus Shing Fung Chui

,

Sai Satish

,

Teguh Santoso

,

Shunsuke Kubo

,

John Chan Kok Meng

,

Kenny Yoong Kong Sin

,

See Hooi Ewe

,

David Sim

,

Edgar Tay

,

Krissada Meemook

,

Shih-Hsien Sung

,

Quang Ngoc Nguyen

,

Xiangbin Pan

,

Makoto Amaki

,

Masaki Izumo

,

Kentaro Hayashida

,

Jung Sun Kim

,

Do-Yoon Kang

,

Gregg Stone

,

Takashi Matsumoto

,

Published:

01 June 2021

Citation:

European Cardiology Review 2021;16:e25.

DOI:

https://doi.org/10.15420/ecr.2021.01
  • Views: Views 2803
  • Downloads: Downloads 164
  • Citations: 3

The ISCHEMIA Trial: What is the Message for the Interventionalist?

Emmanuel Ako

,

Sukhjinder Nijjer

,

Abtehale Al-Hussaini

,

Raffi Kaprielian

,

Published:

01 June 2021

Citation:

European Cardiology Review 2021;16:e24.

DOI:

https://doi.org/10.15420/ecr.2020.37
  • Views: Views 4767
  • Downloads: Downloads 293

Comments on TARGET FFR and DEFINE-FLOW Trials Presented at TCT Connect 2020

Andreas Seitz

,

Stefan Baumann

,

Udo Sechtem

,

Peter Ong

,

Published:

27 April 2021

Citation:

European Cardiology Review 2021;16:e17.

DOI:

https://doi.org/10.15420/ecr.2021.04
  • Views: Views 794
  • Downloads: Downloads 52
  • Citations: 1